|Articles|December 10, 2015
New EU Clinical Trials Regulation: One of the Most Important Changes in the Field in the Past Decade
Author(s)DIA
Advertisement
The EU has issued Regulation 536/2014 of the European Parliament and of The Council on Clinical Trials on Medicinal Products for Human Use, groundbreaking legislation that will allow sponsors to obtain both regulatory and ethics approval through one single portal when it is implemented at the end of 2017.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Single-Injection, Once-Monthly Maintenance Regimen for Lilly’s Omvoh in Ulcerative Colitis
2
Pharmaceutical Executive Daily: Organon CEO Kevin Ali Resigns
3
GSK Enters $745 Million Worldwide Exclusive License Agreement with Empirico for Clinical-Stage First-In-Class Oligonucleotide Candidate
4
FDA Expands Indication for Merck’s Winrevair in Pulmonary Arterial Hypertension
5
